TenNor Therapeutics (Suzhou) Limited disclosed that non-executive director Michael James Bakes resigned from the Board on 5 June 2026 owing to a change in personal job assignment. His departure also ends his role on the Board’s Remuneration and Appraisal Committee.

The resignation leaves the committee with fewer than the required three members. In line with its Articles of Association and the committee’s terms of reference, TenNor Therapeutics plans to appoint a replacement within three months of the effective date.

The Board confirmed that Mr. Bakes has no disagreement with management and that no matters related to his departure require shareholder attention. The Board expressed appreciation for his contributions during his tenure.

Post-resignation, the Board consists of: • Executive Director: Dr. Ma Zhenkun • Non-Executive Director: Dr. Song Gaoguang • Independent Non-Executive Directors: Mr. Lee Wai Kong, Albert; Dr. Ni Lin; Dr. Li Leping

Dr. Ma Zhenkun remains chairman, chief executive officer and general manager of the company.